Impact of the ‘2 week wait’ directive for suspected cancer on service provision in a symptomatic breast clinic

Abstract

Background The ‘2 week wait’ directive (Health Service Circular (HSC) 1998/242) guaranteeing that ‘everyone with suspected breast cancer will be able to see a specialist within two weeks of their general practitioner (GP) deciding they need to be seen urgently’ is a unique audited approach to access for the British National Health Service, the effects of which have been assessed in a non-academic symptomatic breast clinic. Methods New GP referrals (n = 607) were reviewed prospectively in two comparable 3-month intervals, beginning 1 April 1998 and 1 April 1999, to determine the probability of a breast cancer diagnosis from the referral letter and the effects of the directive on waiting times for appointments and utilization of clinics. Results The urgency of referral was not specified in 53 per cent of GP referrals. For the ‘urgent’ cases (25 per cent of all new referrals) the probability of a final diagnosis of breast cancer was 0·19. The breast specialists prospectively achieved a rate of 0·26 from 99 per cent of the same referral letters. ‘Urgent’ referrals did not wait significantly longer in 1999 (median 9 versus 10 days) but waiting times for new appointments overall increased (13 versus 16 days; P < 0·01), and this was greatest for ‘routine’ referrals (14 versus 21 days; P < 0·001). These changes were caused by an increase in the number of clinic appointments, due to significant increases in median number of visits to diagnosis or discharge and clinic non-attendance in 1999, resulting in overbooking. Telephonic communications were associated with faster median access times (fax 8 days; telephone 2 days), relative to mailed referrals (19 days) (P < 0·01). Conclusion Breast specialists were better overall at assessing the probability of a breast cancer diagnosis. The waiting time for ‘urgent’ appointments was unchanged following HSC 1998/242, but there was an increased wait for other patients, especially those assessed as having a lower probability of cancer.